(Q33612543)

28 July 2017

Separating the mechanism-based and off-target actions of cholesteryl ester transfer protein inhibitors with CETP gene polymorphisms (English)

1 reference

28 July 2017

7

1 reference

28 July 2017

24

1 reference

28 July 2017

31

1 reference

28 July 2017

38

1 reference

28 July 2017

Cornelia M. van Duijn

34

Cornelia M van Duijn

0 references

Pim van der Harst

17

Pim van der Harst

1 reference

28 July 2017

56

Debbie A Lawlor

0 references

Mika Kivimäki

14

Mika Kivimaki

0 references

Fabiana Quagliarini

Fabiana Quagliarini

26

0 references

John F Thompson

John F Thompson

22

0 references

Meena Kumari

Meena Kumari

13

0 references

Michael J Pencina

Michael Pencina

35

0 references

Folkert Asselbergs

Folkert W Asselbergs

16

0 references

Philippa Talmud

Philippa J Talmud

5

0 references

Stephen E Humphries

Steve E Humphries

4

0 references

Wiek H van Gilst

Wiek H Van Gilst

21

0 references

Michael Marmot

Michael Marmot

15

0 references

Ramachandran S. Vasan

Ramachandran S Vasan

36

0 references

George Davey Smith

George Davey Smith

58

0 references

Aroon Hingorani

2

Aroon D Hingorani

1 reference

28 July 2017

Valerie McCormack

55

0 references

Liam Smeeth

3

Liam Smeeth

1 reference

28 July 2017

11

Nicholas Wareham

1 reference

28 July 2017

54

Naveed Sattar

1 reference

28 July 2017

12

Kay Tee Khaw

1 reference

28 July 2017

Dirk J van Veldhuisen

20

Dirk J van Veldhuisen

1 reference

28 July 2017

52

Dilys Freeman

1 reference

28 July 2017

Jacqueline C M Witteman

33

Jacqueline C M Witteman

1 reference

28 July 2017

57

Shah Ebrahim

1 reference

28 July 2017

59

John J P Kastelein

1 reference

28 July 2017

8

Manjinder S Sandhu

1 reference

28 July 2017

1

Reecha Sofat

1 reference

28 July 2017

60

John Deanfield

1 reference

28 July 2017

9

Sally L Ricketts

1 reference

28 July 2017

19

Gerjan Navis

1 reference

28 July 2017

41

Heikki Kauma

1 reference

28 July 2017

43

Y Antero Kesäniemi

1 reference

28 July 2017

10

S Matthijs Boekholdt

1 reference

28 July 2017

50

Benjamin D Horne

1 reference

28 July 2017

Ralph B. D'Agostino Sr.

37

Ralph B D'Agostino

1 reference

28 July 2017

Jackie Cooper

6

1 reference

28 July 2017

Robin P F Dullaart

18

1 reference

28 July 2017

Pamela McCaskie

23

1 reference

28 July 2017

Marcello Arca

25

1 reference

28 July 2017

Carlo Gaudio

27

1 reference

28 July 2017

François Cambien

28

1 reference

28 July 2017

Viviane Nicaud

29

1 reference

28 July 2017

Odette Poirer

30

1 reference

28 July 2017

Aaron Isaacs

32

1 reference

28 July 2017

Tricia Y Li

39

1 reference

28 July 2017

Sakari Kakko

40

1 reference

28 July 2017

Markku J Savolainen

42

1 reference

28 July 2017

Anton Sandhofer

44

1 reference

28 July 2017

Bernhard Paulweber

45

1 reference

28 July 2017

Jose V Sorli

46

1 reference

28 July 2017

Akimoto Goto

47

1 reference

28 July 2017

Shinji Yokoyama

48

1 reference

28 July 2017

Kenji Okumura

49

1 reference

28 July 2017

Chris Packard

51

1 reference

28 July 2017

Ian Ford

53

1 reference

28 July 2017

Juan P Casas

61

1 reference

28 July 2017

language of work or name

English

0 references

publication date

21 December 2009

1 reference

28 July 2017

1 reference

28 July 2017

121

1 reference

28 July 2017

1

1 reference

28 July 2017

52-62

1 reference

Polymorphism in the CETP gene region, HDL cholesterol, and risk of future myocardial infarction: Genomewide analysis among 18 245 initially healthy women from the Women's Genome Health Study

28 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2811869

Genetic variants associated with myocardial infarction risk factors in over 8000 individuals from five ethnic groups: The INTERHEART Genetics Study

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2811869

Genome-wide association study identifies eight loci associated with blood pressure

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2811869

Genome-wide association study of blood pressure and hypertension

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2811869

Efficacy and safety of the cholesteryl ester transfer protein inhibitor anacetrapib as monotherapy and coadministered with atorvastatin in dyslipidemic patients

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2811869

Cholesteryl ester transfer protein inhibitor torcetrapib and off-target toxicity: a pooled analysis of the rating atherosclerotic disease change by imaging with a new CETP inhibitor (RADIANCE) trials

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2811869

Association of cholesteryl ester transfer protein genotypes with CETP mass and activity, lipid levels, and coronary risk

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2811869

Torcetrapib-induced blood pressure elevation is independent of CETP inhibition and is accompanied by increased circulating levels of aldosterone

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2811869

A genome-wide association study identifies protein quantitative trait loci (pQTLs)

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2811869

Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2811869

Newly identified loci that influence lipid concentrations and risk of coronary artery disease

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2811869

Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2811869

Effects of torcetrapib in patients at high risk for coronary events

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2811869

Torcetrapib and carotid intima-media thickness in mixed dyslipidaemia (RADIANCE 2 study): a randomised, double-blind trial

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2811869

Effect of torcetrapib on carotid atherosclerosis in familial hypercholesterolemia

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2811869

CETP inhibitors to increase HDL cholesterol levels

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2811869

Effect of torcetrapib on the progression of coronary atherosclerosis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2811869

Efficacy and safety of torcetrapib, a novel cholesteryl ester transfer protein inhibitor, in individuals with below-average high-density lipoprotein cholesterol levels

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2811869

Effects of an inhibitor of cholesteryl ester transfer protein on HDL cholesterol

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2811869

Raising high-density lipoprotein in humans through inhibition of cholesteryl ester transfer protein: an initial multidose study of torcetrapib

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2811869

Measuring inconsistency in meta-analyses

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2811869

‘Mendelian randomization’: can genetic epidemiology contribute to understanding environmental determinants of disease?*

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2811869

Natural genetic variation as a tool in understanding the role of CETP in lipid levels and disease

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2811869

New functional promoter polymorphism, CETP/-629, in cholesteryl ester transfer protein (CETP) gene related to CETP mass and high density lipoprotein cholesterol levels: role of Sp1/Sp3 in transcriptional regulation

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2811869

Monoclonal antibody inhibition of cholesteryl ester transfer protein activity in the rabbit. Effects on lipoprotein composition and high density lipoprotein cholesteryl ester metabolism

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2811869

Genome-wide scan identifies variation in MLXIPL associated with plasma triglycerides

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2811869

Effect of the cholesteryl ester transfer protein inhibitor, anacetrapib, on lipoproteins in patients with dyslipidaemia and on 24-h ambulatory blood pressure in healthy individuals: two double-blind, randomised placebo-controlled phase I studies

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2811869

Effectiveness of inhibition of cholesteryl ester transfer protein by JTT-705 in combination with pravastatin in type II dyslipidemia

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2811869

Effect of antisense oligonucleotides against cholesteryl ester transfer protein on the development of atherosclerosis in cholesterol-fed rabbits

30 October 2018

1 reference

12 December 2020

An overview of 37 randomised trials of blood pressure lowering agents among 270,000 individuals. World Health Organization-International Society of Hypertension Blood Pressure Lowering Treatment Trialists' Collaboration

1 reference

12 December 2020

Nature's randomised trials

1 reference

12 December 2020

Estimation of bias in nongenetic observational studies using "mendelian triangulation"

1 reference

12 December 2020

High-density genotyping and functional SNP localization in the CETP gene

1 reference

12 December 2020

Mendelian randomization: Using genes as instruments for making causal inferences in epidemiology

1 reference

12 December 2020

10.1161/CIRCULATIONAHA.109.865444

Identifiers

DOI

1 reference

28 July 2017

1 reference

28 July 2017

1 reference